Letters to the Editor

Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells

Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498
Department of Hematology, Ibaraki Prefectural Central Hospital, Kasama, Ibaraki 309-1793
Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498
Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498
Oncology Division, Bristol-Myers Squibb K.K., Shinjuku, Tokyo 163-1327
Oncology Division, Bristol-Myers Squibb K.K., Shinjuku, Tokyo 163-1327
The Institute of Medical Science, The University of Tokyo, Minato, Tokyo 108-8639, Japan; Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511 Japan
Department of Hematology, University of Tokushima, Tokushima 770-8503
Department of Orthodontics and Dentofacial Orthopedics, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8504
Department of Hematology, Kawashima Hospital, Tokushima 770-0011
Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498
Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Tochigi 329-0498, Japan; Center for Medical Education, Teikyo University of Science, Tokyo 120-0045
Haematologica Early view Jun 13, 2024 https://doi.org/10.3324/haematol.2024.285368